4//SEC Filing
OncoMed Pharmaceuticals Inc 4
Accession 0001140361-17-016768
CIK 0001302573operating
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 6:13 PM ET
Size
7.2 KB
Accession
0001140361-17-016768
Insider Transaction Report
Form 4
Hoey Timothy
SVP, Cancer Biology
Transactions
- Award
Common Stock
2017-04-23+20,000→ 77,225 total - Award
Stock Option (Right to Buy)
2017-04-23+60,000→ 60,000 totalExercise: $3.73Exp: 2027-04-22→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof.
- [F2]Includes 32,500 RSUs.
- [F3]The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001302573
Filing Metadata
- Form type
- 4
- Filed
- Apr 24, 8:00 PM ET
- Accepted
- Apr 25, 6:13 PM ET
- Size
- 7.2 KB